This article is mentioned in:

Introduction

Acute pulmonary embolism (PE) is a major challenge for emergency facilities. On average, 90% of all mortalities occur within 2 h of the onset of the symptoms (1). Therefore, the rapid treatment of fulminant PE is a high priority. The optimization of emergency structures has been demonstrated to significantly reduce the mortality rate from unstable PE (2). The reliable exclusion of PE in hemodynamically stable patients remains an additional problem, since in a number of these patients, the symptoms of PE are barely evident or manifest in an atypical manner. Previous studies have shown that PE has been frequently overlooked as a result, and that the mortality rate in such cases is significantly increased (3,4). The most important diagnostic method in suspected cases of PE is computed tomography (CT) scans of the pulmonary artery (5,6).

In 2008, the European Society of Cardiology (ESC) published guidelines for the diagnosis and management of PE (7). These recommendations were based on risk stratification using scores, such as the Wells and Geneva scores (8–10). The most important consequence of the ESC guidelines was a low-threshold indication for CT to take into account the diagnostic uncertainty, as aforementioned. The clinical significance of various factors within the guidelines has been discussed controversially by certain authors (11). Furthermore, the risk of overdiagnosis via the detection of an increasing number of clinically-unapparent subsegmental PEs is similarly controversial.

Overall, despite the publication of ESC guidelines, there remains uncertainty with regard to the risk assessment of PE. Against this background, patients with a suspected PE who were admitted to the Emergency Department of the University Medical Center Mannheim (Mannheim, Germany) in 2010 and 2011 were retrospectively studied and the collected data were published in a previous study (12). The focus of that study was on the incidence rate of PE in cases with low-threshold CT indications and the significance of the laboratory diagnostic markers, troponin and D-dimers (12). Patients with the cardinal symptoms of chest pain, dyspnoea and syncope were included, since these symptoms have been frequently observed in patients with a PE in previous studies (13–17).

The aim of the present study was to address the significance of PE risk factors in the patient collective, as aforementioned. In terms of the risk profile of PE, various factors have been proposed by previous studies, including a prior PE or a history of deep vein thrombosis (DVT), obesity, smoking, use of oral contraceptives, thrombophilia, recent long distance flying, malignant disease and immobilization (18–21). However, in general, the patient collectives studied have been small and of heterogeneous quality. Therefore, accurate evaluation of the risk profile in cases suspected of a PE may be important in the context of the current ESC recommendations and in light of the uncertainties described.

Materials and methods

Study population

In the study, the medical records of 492 patients who were admitted to the Emergency Department of the University Hospital of Mannheim in the period between April 2010 and July 2011 were retrospectively analyzed. Due to the retrospective nature of the study protocol, the institutional ethical review board of the University Medical Center Mannheim waived the requirement for informed patient consent. All the patients presented with cardinal symptoms of chest pain, dyspnoea or syncope, and tested positive for the D-dimer test for PE exclusion. The patients were hemodynamically stable and met the criteria of a low or moderate probability of PE, according to the Wells score (10).

The specific risk profile of all the patients was documented following their admission to the Emergency Department. In the documentation, a number of factors, including obesity, smoking, use of contraceptives, immobility level, history of malignant disease and thrombophilia, family history, history of DVT/PE, long-distance flying <1 week prior to admission and surgery during the four preceding weeks, were recorded.

Furthermore, the diagnosis standard comprised a physical examination and a 12-lead electrocardiography (GE MAC 1200 ST; GE Healthcare, Freiburg, Germany). As laboratory risk markers, the levels of D-dimers (TINA-quant; Roche Diagnostics, Mannheim, Germany), as a parameter of acute coagulation activation, and high-sensitivity troponin (Siemens Healthcare Diagnostics, Eschborn, Germany), a marker of cardiac cell death, were determined. In the case of the presence of any of the described cardinal symptoms in combination with a positive D-dimer test, a pulmonary artery CT examination (Somatom Emotion, Siemens Medical Solutions, Forchheim, Germany) was performed. CT was considered a contraindication for pregnant women and patients with contrast medium allergy, higher-grade renal insufficiency (creatinine level of >1.5 mg/dl) or hyperthyroidism, as well as in cases of ongoing metformin therapy. In patients with these contraindications, no acute CT examination was performed.

Statistical analysis

For statistical analysis, JMP 9.0.0 (SAS Institute, Inc., Cary, NC, USA), MedCalc 12.7.0 (MedCalc Software bvba, Ostend, Belgium) and Forest Plot Viewer 1.0 (National Institute of Environmental Health Sciences, Durham, NC, USA) software packages were used. Nominal variables are depicted as numbers (percentages). For each continuous variable, the Shapiro-Wilk test was applied to assess for Gaussian distribution of the data. Parametric and nonparametric continuous variables are expressed as the mean ± standard deviation and as the median (1st and 3rd quartiles), respectively. Furthermore, value ranges (minimum and maximum) were presented. As a measure for the quantitative estimation of the risk of PE in cases with the presence of a risk factor, the odds ratio (OR) and the 95% confidence interval (CI) were calculated. A value of P<0.05, based on two-sided significance testing, was considered to indicate a statistically significant difference.

Results

Patient characteristics

Baseline characteristics of the patients are summarized in Table I. The specific risk profiles of the 492 patients with a suspected PE, including the number and percentage of patients (n, %) and the single risk factor ORs for the presence of PE, are listed in Table II. As shown in Fig. 1, the ORs were compared in the form of a Forest plot graph. The risk of PE was significantly increased with each of the following factors: Thrombophilia (OR, 11.5, P=0.008), use of contraceptives (OR, 4.9, P=0.03) and history of DVT/PE (OR, 3.08, P=0.003). Surgery <4 weeks previously (OR, 1.58, P=0.42), immobility level (OR, 2.84, P=0.13) and long-distance flying <1 week previously (OR, 3.78, P=0.13), as well as family history of DVT/PE (OR, 5.03, P=0.08), neoplastic disease (OR, 1.11, P=0.82) and obesity (OR, 1.22, P=0.64) were shown to increase the risk of PE; however, the difference was not statistically significant. In the comprised collective, smoking was not found to be associated with an increased risk of PE (OR, 0.73, P=0.47).

Figure 1. Forest plot demonstrating the odds ratios for the risk factors of patients (n=492) with a suspected PE. *P<0.05 which demonstrates a significant association between the risk factor and an increased risk of PE. PE, pulmonary embolism; DVT, deep vein thrombosis; CI, confidence interval.

Table I. Baseline characteristics of 492 patients with a suspected pulmonary embolism.

Table I.

Baseline characteristics of 492 patients with a suspected pulmonary embolism.

Characteristic	All patients (n=492)
Age, years
Mean ±SD	68±17
Range	19–105
Gender, n (%)
Male	218 (44)
Female	274 (56)
Symptoms, n (%)
Chest pain	257 (52)
Dyspnoea	281 (57)
Syncope	81 (16)
Heart rate, bpm
Mean ± SD	86±22
Range	49–175
Systolic blood pressure, mmHg
Mean ± SD	147±29
Range	90–290
Diastolic blood pressure, mmHg
Mean ± SD	80±15
Range	40–150
Oxygen saturation, %
Mean ± SD	96±4
Range	70–100

[i] SD, standard deviation.

Table II. Risk factors in patients (n=492) with a suspected PE.

Table II.

Risk factors in patients (n=492) with a suspected PE.

Risk factor	Cases, n (%)	OR	95% CI	P-value
Obesity	50 (10.2)	1.22	0.52–85	0.64
Smoking	74 (15.0)	0.73	0.32–1.69	0.47
Oral contraceptives	8 (1.6)	4.90	1.11–21.59	0.03a
Tumor diseases	46 (9.3)	1.11	0.45–2.75	0.82
History of DVT/PE	41 (8.3)	3.08	1.45–6.54	0.003a
Family history of DVT/PE	5 (1.0)	5.03	0.82–30.74	0.08
Thrombophilia	5 (1.0)	11.50	1.89–70.60	0.008a
Long distance flight <1 week	6 (1.2)	3.78	0.67–21.01	0.13
Immobility	11 (2.2)	2.84	0.73–11.04	0.13
Surgery <4 weeks	23 (4.7)	1.58	0.62 to 4.83	0.42

a P<0.05 which demonstrates a significant association between the risk factor and an increased risk of PE. DVT, deep vein thrombosis; PE, pulmonary embolism; OR, odds ratio; CI, confidence interval.

Discussion

In hemodynamically stable patients, the optimal workflow for the exclusion of a PE remains subject to uncertainty. The ESC guidelines for PE published in 2008 took this into account by recommending a low-threshold CT indicator for patients with a suspected PE. However, this strategy is considered controversially with regard to the possibility of overdiagnosis of patients, such as by the detection of unapparent subsegmental PEs. Therefore, relevant criteria for further optimization of the risk assessment of these patients is required.

Traditionally, risk factors play an important role in the diagnostic workup of patients with cardiovascular disease. In acute coronary syndrome, for example, the risk factors of coronary heart disease are mapped by relevant scores, such as the Thrombolysis In Myocardial Infarction score (criterion, ≥3 risk factors) (22). Similarly, with regard to PE, a number of risk factors are known, as previously described. However, the Wells score considers only the factors of immobilization or surgery <4 weeks previously, prior history of DVT or PE and malignant disease <6 months previously (10). In addition, the Geneva score only includes the criteria of a prior history of DVT or PE, surgery or fracture <4 weeks previously and active malignancy (9). Other parameters, including obesity, smoking, use of oral contraceptives, thrombophilia and recent long distance flying, are described in the literature; however, are not included into the scores recommended by the ESC (18–21). Therefore, the predictive value of considering these risk factors in the context of modern PE diagnostics is yet to be determined.

The aim of the present study was to re-evaluate the risk factors of PE in their entirety, and particularly in synopsis with the ESC recommendations published in 2008 and updated in 2014. The current study met the low-threshold indicators for CT, as demanded by the ESC, and thus the modern requirements of PE diagnosis. The results of the present study demonstrated a significant risk of PE for the criterion of contraceptive use and a highly significant risk of PE for the parameters of a history of DVT/PE and thrombophilia. History of DVT/PE is included in the two previously mentioned scoring systems within the ESC guidelines. By contrast, the factors of contraceptive use and thrombophilia are not included in the Wells or Geneva scores. This diagnostic deficiency is, however, difficult to assess. The association between oral contraceptives and PE is established, although only a limited number of studies address the issue (20,23). Of these, the study by Lauque et al comprised only 11 case reports and is not recent (20). Significantly more data exist with regard to the association between DVT and contraceptive use. A meta-analysis by Manzoli et al included a considerable number of studies and confirmed a significantly increased risk of thrombosis with oral contraceptive use (23). Despite the wealth of data, the results concerning DVT cannot be transferred directly to PE. Nevertheless, the association between oral contraceptives and PE remains undisputed. With regard to the association between thrombophilia and PE, the data of the Lauque et al study are similarly weak. Data from a large retrospective study by Wu et al indicated a significantly increased risk of PE associated with different thrombophilia subgroups; the risk increased further upon concomitant intake of contraceptives (24). Thus, the risk factors of contraceptive use and thrombophilia, in addition to a history of DVT/PE, are of significant importance in the context of PE.

In conclusion, the results of the present study demonstrate that emphasis should be focused on the risk factors of contraceptive use, thrombophilia and a history of DVT/PE, in addition to previously used diagnostic parameters, such as D-dimer testing, in the overall assessment of PE risk. Patients with a suspected PE and at least one of the aforementioned risk factors should be referred for CT diagnosis even in the absence of elevated levels of D-dimers, since a number of PE cases that tested negative for D-dimer have been reported (25).

References